The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)

NCT00816907 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

146

Enrollment

NIH

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Metformin
DRUG: Placebo

Sponsor

National Institute of Mental Health (NIMH)